← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
International Ctr/Diarrhoeal Dis Res
Dhaka
$76,332,804
Total funding
18
Grants
Funding over time
peak $6.6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
CDC$69,620,613 · 8
NIH$6,712,191 · 10
By mechanism
U01$70,583,408 · 8
U51$1,897,962 · 1
N01$1,441,812 · 1
K43$1,169,111 · 3
R01$617,301 · 1
R21$269,279 · 1
Investigators at International Ctr/Diarrhoeal Dis Res
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Largest grants
ADDRESSING EMERGING INFECTIONS DISEASE IN BANGLADESH$5,228,477
U01 · FY2015 · GH
ADDRESSING EMERGING INFECTIOUS DISEASES IN BANGLADESH$4,882,450
U01 · FY2011 · CI
ADDRESSING EMERGING INFECTIONS DISEASE IN BANGLADESH$4,797,712
U01 · FY2016 · GH
RFA-GH-24-033, Advancing Public Health Research in Bangladesh$3,960,721
U01 · FY2024 · GH
ADDRESSING EMERGING INFECTIOUS DISEASES IN BANGLADESH$3,919,682
U01 · FY2013 · CI
ADDRESSING EMERGING INFECTIONS DISEASE IN BANGLADESH$3,729,101
U01 · FY2017 · GH
RFA-GH-19-004, Advancing Public Health Research in Bangladesh$3,588,493
U01 · FY2023 · GH
ADDRESSING EMERGING INFECTIOUS DISEASES IN BANGLADESH$3,375,299
U01 · FY2012 · CI
ADDRESSING EMERGING INFECTIONS DISEASE IN BANGLADESH$3,318,845
U01 · FY2018 · GH
GH19-005, Advancing Public Health Research in Bangladesh$2,987,356
U01 · FY2020 · GH
ADDRESSING EMERGING INFECTIONS DISEASE IN BANGLADESH$2,962,803
U01 · FY2014 · GH
ADDRESSING EMERGING INFECTIOUS DISEASES IN BANGLADESH$2,895,593
U01 · FY2009 · CI
Advancing Public Health Research in Bangladesh$2,879,788
U01 · FY2021 · GH
ADDRESSING EMERGING INFECTIOUS DISEASES IN BANGLADESH$2,375,032
U01 · FY2010 · CI
Advancing Public Health Research in Bangladesh$2,298,943
U01 · FY2019 · GH
Addressing Emerging Infectious Disease in Bangladesh$2,194,950
U01 · FY2008 · CI
Addressing Emerging Infectious Disease in Bangladesh$1,935,726
U01 · FY2006 · CI
EFFICACY OF OSELTAMIVIR IN REDUCING DURATION OF ILLNESS, VIRAL SHEDDING & TRANSIS$1,495,758
U01 · FY2007 · IP
Addressing Emerging Infectious Disease in Bangladesh$1,477,702
U01 · FY2007 · CI
Global Health Activities in Developing Countries to Combat Non-Communicable Chron$1,323,943
N01 · FY2009 · HL